BrainStorm Cell Therapeutics has received a notice of allowance from the US Patent Office for its ‘Mesenchymal Stem Cells for the Treatment of CNS Diseases’ (serial number 12/994,761) patent application. This patent relates to ...
Tags: Cell Technology Patent, Medicine
A new study has found that adolescents and young adults undergoing cancer treatment gain coping skills and resilience-related outcomes when they participate in a therapeutic music process that includes writing song lyrics and producing ...
Researchers from Massachusetts Eye and Ear,Harvard Medical School,Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated,for the first time,that aspirin intake correlates with halted growth of vestibular ...
Tags: Aspirin Intake, Aspirin, Intracranial Tumor
LONDON, Jan. 26 (UPI) -- GlaxoSmithKline says it received a positive opinion in Europe for albiglutide, under the brand name Eperzan, for treatment of type 2 diabetes. GSK officials said the Committee for Medicinal Products for Human Use ...
Tags: Albiglutide, Glaxosmithkline, FDA
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Novartis’ Xolair (omalizumab) as an add-on therapy for the treatment of chronic spontaneous ...
High school students who were at risk for dropping out greatly improved their math test scores and school attendance with the help of intensive tutoring and mentoring, according to a new study by the University of Chicago Urban Education ...
Tags: CPS, educational strategies, NBER, education policy
As the Northeast and mid-Atlantic joined the Midwest in dealing with yet another deep freeze on Tuesday, doctors are offering advice on dealing with frigid temperatures. "It's best to limit your outdoor activity as much as possible, since ...
Tags: frigid temperatures, affect the brain, physician treat
The website Wikipedia is the single leading source of medical information for U.S. patients and healthcare professionals, an information services company says. A report by IMS Health, a global information and technology services company, ...
Tags: Medical Information, Wikipedia
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...
Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier
The project is the result of an initiative of Spanish people affected by this rare disease. FARA, one of the main patients' associations in the United States now joins the endeavour The gene therapy-based research project to tackle ...
Tags: FARA, CBMSO, GENEFA Platform, IRB
Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...
US-based FOB Synthesis and AstraZeneca have entered into a research and development option and license agreement for the development of a novel antibiotic for the treatment of drug-resistant bacterial infections. The new antibiotics will ...
Tags: FOB, BLI, AstraZeneca
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketing authorisation application (MAA) for BEMFOLA (follitropin alfa solution for injection in ...
Medtech giant St. Jude Medical announced a major reorganization and leadership changes on Tuesday. The Little Canada, MN–based company says its two operating divisions will be integrated into one research and development ...
Sapheon has announced the Health Canada approval for its VenaSeal sapheon closure system, designed to treat venous reflux disease (varicose veins). VenaSeal features a specially formulated medical adhesive that closes the saphenous vein. ...